Podcasts about Melanoma

Redheads are bullied, fetishized, and medically misunderstood. Jessica Wynn is here to color in the facts about being a ginger on this Skeptical Sunday!Welcome to Skeptical Sunday, a special edition of The Jordan Harbinger Show where Jordan and a guest break down a topic that you may have never thought about, open things up, and debunk common misconceptions. This time around, we're joined by writer and researcher Jessica Wynn!Full show notes and resources can be found here: jordanharbinger.com/1219On This Week's Skeptical Sunday:The MC1R gene mutation causes red hair, pale skin, and freckles, but also influences pain processing, drug metabolism, and other biological functions throughout the body.Redheads experience pain differently — they tolerate electric shocks better but are more sensitive to heat and cold, requiring adjusted medical treatment approaches.Redheads have significantly higher melanoma risk because they produce less protective melanin, making sunscreen essential and frequent sun exposure dangerous.Redheads face ongoing discrimination and fetishization — from childhood bullying to adult harassment — despite red hair being a normal genetic variation affecting one to two percent of the population.Research on redheads' unique genetics is advancing pain treatment for everyone. Understanding genetic diversity helps medicine better serve all patients, not just those with red hair.Connect with Jordan on Twitter, Instagram, and YouTube. If you have something you'd like us to tackle here on Skeptical Sunday, drop Jordan a line at jordan@jordanharbinger.com and let him know!Connect with Jessica Wynn at Instagram and Threads, and subscribe to her newsletters: Between the Lines and Where the Shadows Linger!And if you're still game to support us, please leave a review here — even one sentence helps! Sign up for Six-Minute Networking — our free networking and relationship development mini course — at jordanharbinger.com/course!Subscribe to our once-a-week Wee Bit Wiser newsletter today and start filling your Wednesdays with wisdom!Do you even Reddit, bro? Join us at r/JordanHarbinger!This Episode Is Brought To You By Our Fine Sponsors:SimpliSafe: 50% off + 1st month free: simplisafe.com/jordanAirbnb: airbnb.com/hostApretude: Apretude.com or call 1-888-240-034Quiltmind: Email jordanaudience@quiltmind.com to get started or visit quiltmind.com for more infoWhat Was That Like: Listen here or wherever you find fine podcasts!See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In today's episode of Barbell Shrugged, Anders, Doug, and Travis dive into Coach Travis' recent melanoma diagnosis, how he found out about it, and his recent surgery to eliminate it. We also dive into Anders' quest to build a gym in the middle of the woods where he plans on lifting giant trees and the latest in strength tech with Travis Mash. Work With Us: Arétē by RAPID Health Optimization Links: Anders Varner on Instagram Doug Larson on Instagram Coach Travis Mash on Instagram

Hosted by Emma King with special guest A/Prof. Michelle Rodrigues Skin of colour deserves centre stage in dermatology conversations. In this podcast, Emma King sits down with internationally recognised dermatologist A/Prof. Michelle Rodrigues to explore the unique challenges, misconceptions, and advances in caring for diverse skin types. From disorders of pigmentation to atopic dermatitis, the discussion sheds light on why awareness and expertise in this field are crucial for both clinicians and patients. Whether you're a healthcare professional or simply passionate about skin health, this podcast will expand your understanding of dermatology in skin of colour and why representation matters in medicine. RESOURCES Dr Michelle Rodrigues, Importance of skin of colour dermatology in the primary care setting in Australia, AJGP https://www1.racgp.org.au/ajgp/2023/october/the-importance-of-skin-of-colour-dermatology-in-th   SEARCH pubmed.ncbi.nlm.nih.gov for publications around skin of colour. British Association of Dermatology Education Resources for clinicians on skin of colour, 2020: https://cdn.bad.org.uk/uploads/2022/02/29200007/Educational-Resources-for-Clinicians-on-Skin-of-Colour-in-Dermatology-2020.pdf   Brown Skin Matters: https://becker.wustl.edu/news/brown-skin-matters/   Dr Jim Muir, Skin of colour, ACCRM https://www.acrrm.org.au/about-us/news-events/media-releases/article/2024/06/21/skin-of-colour-by-dr-jim-muir   National Eczema Society, Skin pigmentation and eczema: https://eczema.org/information-and-advice/living-with-eczema/skin-pigmentation/   Vitiligo Foundation: https://vrfoundation.org/?gad_source=1&gad_campaignid=191484605&gbraid=0AAAAADnlk7uwzIuMpeU6AmZh29dFSd3-P&gclid=Cj0KCQjw3OjGBhDYARIsADd-uX5rMty_3i6mZwJpsu2ahcpcQsRZegdX22F5FbLDd65EMFvfgtCw2RgaAmTVEALw_wcB   Dermnet, Dermatological conditions in skin of colour: https://dermnetnz.org/topics/skin-conditions-in-skin-of-colour   Dermnet; Melanoma in skin of colour: https://dermnetnz.org/topics/melanoma-in-skin-of-colour   Dermnet, Ethnic  dermatology: https://dermnetnz.org/topics/ethnic-dermatology

In this episode of the Oncology Brothers podcast, we are joined by Dr. Omid Hamid, a melanoma specialist from Cedars-Sinai, to explore the current treatment landscape of cutaneous melanoma. We covered a wide range of topics, including: •⁠  ⁠The standard of care for early-stage melanoma, including wide local excision and sentinel lymph node evaluation. •⁠  ⁠The role of adjuvant immunotherapy and BRAF/MEK inhibitors for high-risk patients. •⁠  ⁠Insights into neoadjuvant treatment options for resectable disease, including recent trial data from NADINA and SWOG S1808. •⁠  ⁠The importance of next-generation sequencing (NGS) and circulating tumor DNA (ctDNA) in treatment planning and monitoring. •⁠  ⁠The evolving treatment paradigm for metastatic melanoma, including the use of dual checkpoint inhibitors and BRAF/MEK inhibitors. Join us as we discuss the latest advancements in melanoma treatment and the critical role of patient education and shared decision-making in oncology care. Follow us on social media: •⁠  ⁠X/Twitter: https://twitter.com/oncbrothers •⁠  ⁠Instagram: https://www.instagram.com/oncbrothers •⁠  Website: https://oncbrothers.com/ Don't forget to subscribe for more episodes on treatment algorithms, new FDA approvals, and conference highlights! #Melanoma #Immunotherapy #BRAF #ctDNA #Neoadjuvant #OncologyBrothers

Today's guest is Kevin Donaghy, stage IV Melanoma survivor and author of Stories of Cancer and Hope, a collection of honest stories from people directly affected by cancer. He works with several cancer charities in the UK, donating thousands of copies of the book as well as proceeds from the sale of the book.We talk about Stage IV cancer, finding community and hope through shared stories, silver linings and new beginnings amidst cancer, advancements in immunotherapy and cancer research, and so much more!Resources:Kevin's Website: https://storiesofcancerandhope.co.uk/Kevin's LinkedIn: https://www.linkedin.com/in/kdonaghy/Kevin's Instagram: https://www.instagram.com/storiesofcancerandhope/Kevin's Facebook: Kevin DonaghyKevin's X: https://x.com/storiesofc62048Stories of Cancer and Hope Book on AmazonFollow:Follow me: https://www.instagram.com/melissagrosboll/My website: https://melissagrosboll.comEmail me: drmelissagrosboll@gmail.com

Dr. Aideen McInerney-Leo explores hereditary melanoma (CDKN2A), diagnostic disclosure in Turner syndrome, mainstreaming genomics, gene therapy, and the expanding role of genetic counsellors in research and patient care. Through clinical stories, family perspectives and practical takeaways on testing and screening, this episode highlights how research and clear communication improve outcomes — with a personal note on the therapeutic craft of bead-making.

La biotecnología chilena ha dado un salto global. Oncobiomed es una empresa creadora de vacunas contra el cáncer, y ha iniciado su expansión hacia China tras sellar una serie de acuerdos, incluidos Shenzhen, una ciudad conocida como la Silicon Valley, de la potencia asiática. Con estas alianzas, la firma busca abrir camino a la ciencia nacional en uno de los mercados más estratégicos para las terapias avanzadas. Vamos a profundizar en este tema, conversamos con el doctor Flavio Salazar, asesor científico de Oncobiomed y académico además de la facultad de medicina de la Universidad de Chile.

No one's buying ABC's excuse about canning Jimmy Kimmel any more than anyone is buying Kash Patel's "Tyler Robinson text messages." Both are equally absurd. Nitwit Nero gets a very special salute in a royal review.  Melanoma, meanwhile is just . . . weird in her Grim Reaper getup. Was she rehearsing wearing widow's weeds? CNN provides a mixed bag on Jimmy Kimmel. There was almost some scant journalism. 

Melanoma en perros y gatos || Animales que dejaron de ser domesticados. Este miércoles en Mascoteando Por el bienestar animal @mascoteando_mx: “Melanoma en perros y gatos” con la MVZ María Becerril y “Animales que dejaron de ser domesticados (No fue buena idea)”. Conducido por el @MVZ Raúl Ocádiz. Los esperamos a las 8 de la noche Mex �, 9 pm Colombia y Perú �� , 10 pm �Chile y 11 pm �Argentina. Velo por ADR Networks en facebook @adrnetworksmx invita. #ActivandoTusSentidos #medicinaveterinaria #veterinario #sedación #perros #gatos #oncologíaveterinaria #melanoma #domesticación

In the season six premiere of the Bench to Bedside podcast, Dr. Roy Jensen, vice chancellor and director of The University of Kansas Cancer Center, sits down with his friend and colleague Dr. Gary Doolittle, medical director of the Masonic Cancer Alliance (MCA) and melanoma expert. Dr. Doolittle shares his personal and professional experiences in oncology, including his own cancer diagnosis and how it has influenced his approach to patient care. They discuss the unique challenges rural communities face in accessing cancer treatment and the role initiatives like the Masonic Cancer Alliance and telemedicine play in improving care accessibility. Dr. Doolittle offers insights from his dual perspective as a physician and a cancer survivor, emphasizing the importance of empathy, swift patient management and building trust in healthcare systems. 00:00 Introduction to Bench to Bedside 00:33 Meet Dr. Gary Doolittle 01:29 Dr. Doolittle's Personal Cancer Journey 03:01 Impact on Patient Care 06:36 Challenges in Rural Cancer Care 12:59 Telemedicine and the MCA 18:50 Advice for Patients and Physicians 21:33 Conclusion and Final Thoughts Links from this Episode: ·       Learn more about Dr. Gary Doolittle ·       Learn more about the Masonic Cancer Alliance ·       Learn more about the MCA's community outreach and engagement efforts For the latest updates, follow us on the social media channel of your choice by searching for KU Cancer Center.

On today's Unemployable, we tackle the hard stuff: why cancer remains our biggest health challenge, why water quality may define the next global conflict, how outbreaks re-enter the U.S. (measles, dengue, bioterror), what COVID actually taught us, and where AI and genomics help—or create new risks. Along the way we talk access to care, compounding vs. brand-name drugs, GLP-1s (Ozempic/Wegovy), and the habits that really move the needle: sleep, strength, hydration, and walking with purpose. My guest is a former U.S. Assistant Secretary for Health and four-star admiral in the U.S. Public Health Service with leadership roles spanning MD Anderson's Moon Shots, WHO, and federal response teams for anthrax and Ebola. It's a masterclass in population health, plain talk, and what leaders should actually do next. Timestamps below. If this helps you think clearer and lead better, hit subscribe and share it with one person who needs it today. Disclaimers: This show is educational only. Nothing here is medical advice. Talk to your doctor before making decisions about screening, vaccines, medications, or treatment. Resources mentioned: • Joxel Garcia's books on Amazon • St. Jude Children's Research Hospital • MD Anderson Moon Shots • CDC/WHO resources on vaccines & outbreaks 

On today's Unemployable, we tackle the hard stuff: why cancer remains our biggest health challenge, why water quality may define the next global conflict, how outbreaks re-enter the U.S. (measles, dengue, bioterror), what COVID actually taught us, and where AI and genomics help—or create new risks. Along the way we talk access to care, compounding vs. brand-name drugs, GLP-1s (Ozempic/Wegovy), and the habits that really move the needle: sleep, strength, hydration, and walking with purpose. My guest is a former U.S. Assistant Secretary for Health and four-star admiral in the U.S. Public Health Service with leadership roles spanning MD Anderson's Moon Shots, WHO, and federal response teams for anthrax and Ebola. It's a masterclass in population health, plain talk, and what leaders should actually do next. Timestamps below. If this helps you think clearer and lead better, hit subscribe and share it with one person who needs it today. Disclaimers: This show is educational only. Nothing here is medical advice. Talk to your doctor before making decisions about screening, vaccines, medications, or treatment. Resources mentioned: • Joxel Garcia's books on Amazon • St. Jude Children's Research Hospital • MD Anderson Moon Shots • CDC/WHO resources on vaccines & outbreaks 

Australia's known for having some of the world's toughest sunscreen standards, but in June, that reputation was rocked. Independent testing of 20 sunscreens found 16 did not meet their advertised SPF50 rating, including three children's sunscreens and three sold by the Cancer Council. So how are sunscreens tested, and what can we learn from these recent SPF revelations?You can binge more episodes of the Lab Notes podcast with science journalist and presenter Belinda Smith on the ABC Listen app (Australia). You'll find episodes on animal behaviour, human health, space exploration and so much more.Get in touch with us: labnotes@abc.net.auFeaturing:John Staton, scientific director at SciPharm More information:Choice report finds popular Australian sunscreens fail to meet SPF claims on labelThis episode of Lab Notes was produced on the lands of the Wurundjeri and Menang Noongar people.

When the “Mole Mobile” came to Ottawa over four days, it was overrun with people. Robyn Bresnahan spoke to people who waited hours to see a dermatologist.

Julie Howle is a talented triathlete and surgical oncologist.She's currently the Head of the Melanoma and Sarcoma Multidisciplinary Groups at Westmead Hospital here in Sydney and a Clinical Senior Lecturer at The University of Sydney.Julie is also an Age Group World Champion triathlete, having won her AG at the ITU Long Distance World Championships in 2017. And she's a 2x finisher for the Hawaii Ironman in Kona (in 2017 and 2018).Plus she's someone who openly admits that her experience of changing degrees at University “laid the foundation for a lifetime of the imposter syndrome”.Julie and I discuss:- how being resilient and focusing on her goals has helped her navigate her experience with the Imposter Complex,- how the words “World Champion” sit with her,- why she took almost 10 years from her first triathlon to do her first Ironman,- why being sick in the week leading up to her 1st Hawaii Ironman at Kona was a good thing,- how she's realised getting stuck in ‘comparison' ruins her enjoyment of the sport,- how she (as a melanoma specialist living here in Australia, a country with one of the highest rates of skin cancer) protects her skin from the sun while training and racing, and- what you need to do to protect and monitor your skin.Julie is such a softly spoken, humble and genuinely lovely woman. I hope you enjoy this conversation as much as I did.

Interview with David C. Whiteman, MBBS, PhD, author of A Risk Prediction Tool for Invasive Melanoma. Hosted by Adewole S. Adamson, MD. Related Content: A Risk Prediction Tool for Invasive Melanoma

Interview with David C. Whiteman, MBBS, PhD, author of A Risk Prediction Tool for Invasive Melanoma. Hosted by Adewole S. Adamson, MD. Related Content: A Risk Prediction Tool for Invasive Melanoma

Dr. Alex Meves, distinguished dermatologist at the Mayo Clinic and a spokesperson for SkylineDx, discusses the challenges in diagnosing and treating melanoma and how a new molecular test called Merlin can help improve risk stratification and treatment decisions for patients with early-stage melanoma. Diagnosis and treatment have traditionally used tumor thickness as a primary risk factor. This molecular test measures the expression of genes in the tumor biopsy and can help determine the extent of surgery needed and whether additional therapies may be beneficial. Alex explains, "My department, when I started to work here at Mayo, wanted me to do some translational research, and I had just come back from a postdoc in Germany, at the Max Planck Institute, and I was tasked to get some research going. And so I focused on melanoma because I thought at the time there wasn't a lot of molecular research going on in melanoma that could be translated to patients. And so we started to develop biomarkers, sort of molecular tests that we could apply to tissue, and then help patients with." "Yes, so the problem that our research is focused on is what to do once you're diagnosed with a melanoma. What you want to do is to match the right therapy to the right patient. That's the goal. There are lots of melanomas that might not be very aggressive, and you don't have to do a lot of treatment. And then there's some melanoma that's very aggressive, and you want to do lots of treatment, but it's not always obvious which melanoma is low risk and which melanoma is high risk. And so this idea of risk stratification at diagnosis becomes very important to match therapy to patients." #skincancer #melanoma #SkylineDx #PersonalizedMedicine #PrecisionDiagnostics skylinedx.com Download the transcript here

Dr. Alex Meves, distinguished dermatologist at the Mayo Clinic and a spokesperson for SkylineDx, discusses the challenges in diagnosing and treating melanoma and how a new molecular test called Merlin can help improve risk stratification and treatment decisions for patients with early-stage melanoma. Diagnosis and treatment have traditionally used tumor thickness as a primary risk factor. This molecular test measures the expression of genes in the tumor biopsy and can help determine the extent of surgery needed and whether additional therapies may be beneficial. Alex explains, "My department, when I started to work here at Mayo, wanted me to do some translational research, and I had just come back from a postdoc in Germany, at the Max Planck Institute, and I was tasked to get some research going. And so I focused on melanoma because I thought at the time there wasn't a lot of molecular research going on in melanoma that could be translated to patients. And so we started to develop biomarkers, sort of molecular tests that we could apply to tissue, and then help patients with." "Yes, so the problem that our research is focused on is what to do once you're diagnosed with a melanoma. What you want to do is to match the right therapy to the right patient. That's the goal. There are lots of melanomas that might not be very aggressive, and you don't have to do a lot of treatment. And then there's some melanoma that's very aggressive, and you want to do lots of treatment, but it's not always obvious which melanoma is low risk and which melanoma is high risk. And so this idea of risk stratification at diagnosis becomes very important to match therapy to patients." #skincancer #melanoma #SkylineDx #PersonalizedMedicine #PrecisionDiagnostics skylinedx.com Listen to the podcast here

After a summer podcasting break, Jim Joyce and I are back and on this episode of #TheShot of #DigitalHealth Therapy, we finally cornered the legendary Erik de Heus, CEO of SkinVision (yes, only 173 episodes in… shame on us). From biking along Amsterdam canals to catching curveballs in Dutch baseball, to scaling energy startups and now leading SkinVision, Erik's story is a mix of persistence, humility, and “just follow your dream” wisdom. If you've ever wondered how a kid bossing his friends on the playground ends up building digital health business that catch melanoma early and save lives at scale - this one's for you. Fun mentions as always: Steve Seuntjens HLTH Inc. Martin Kelly ⧉ 00:00 – 02:00 | Opening banter – Jim & Eugene finally get Erik on the mic. ⧉ 02:00 – 06:00 | Early career & HP days – Amsterdam to California and back. ⧉ 06:00 – 09:00 | Childhood & sports – Football, baseball, and bossing friends. ⧉ 10:00 – 15:00 | Energy startup journey – From inception to €500M revenue. ⧉ 15:00 – 20:00 | Scaling challenges – Processes, people, and persistence. ⧉ 22:00 – 28:00 | Philips DirectLife – Competing with Fitbit + coaching layer. ⧉ 30:00 – 33:00 | Birth of PHS Capital – Early digital health investing. ⧉ 34:00 – 41:00 | SkinVision origins – Melanoma detection at scale. ⧉ 42:00 – 47:00 | Aligning incentives – Insurance, NHS, and consumer trust. ⧉ 47:00 – 54:00 | Erik's advice & future vision – Follow your dream, validate the problem.

The incidence and prevalence of cutaneous melanoma in the US and worldwide have increased over the last 5 decades. JAMA Review Author John Kirkwood, MD, discusses the epidemiology, risk factors, treatment, and prevention of melanoma with JAMA Deputy Editor Kristin Walter, MD, MS. Related Content: Cutaneous Melanoma ----------------------------------- JAMA Editors' Summary

In today's episode, supported by Immatics, we spoke with Jason Luke, MD, about the development of the PRAME-directed T-cell receptor (TCR) T-cell therapy IMA203 in the ongoing phase 3 SUPRAME trial (NCT06743126) in patients with previously treated, unresectable or metastatic cutaneous melanoma. In our conversation, Dr Luke discussed the rationale for evaluating IMA203 in patients with cutaneous melanoma, the mechanism of action of this novel drug, the design of this study, earlier data that support the continued investigation of this agent in this population, and what these findings may mean for the future of TCR therapy in melanoma.

We're honored to welcome Dr. Carol Shields, one of the world's leading ocular oncologists and Director of the Oncology Service at Wills Eye Hospital, to the Eye Believe Podcast by A Cure In Sight.

Ted Komenda 54 year old Melanoma patient and Dr. Beth Buchbinder.

3pm Hour: Jason talks about the experience of bringing his youngest to college, and how life-changing that feels. Then he talks with dermatologist Dr. Mohiba Tareen about the spotlight being shined on the deadly disease of melanoma.

Jason talks to dermatologist Dr. Mohiba Tareen about some melanoma cases in the news and the increased awareness of this deadly disease.

O cantor Clemente, intérprete de sucessos como “Vais Partir”, faz uma reflexão sobre a sua vida e a sua carreira. Aos 69 anos, o artista acredita que está a passar a melhor fase da sua vida e que agora pode, finalmente, dizer aquilo que pensa. Numa entrevista emotiva, Clemente recorda também o momento, há cinco anos, em que lhe foi diagnosticado um melanoma de grau quatro: “Entrei no carro e chorei durante 15 minutos. Que seja feita a vontade de Deus”. Este programa foi inicialmente emitido na SIC a 29 de junho de 2024, recorde aqui o testemunho do cantor com a versão podcast do 'Alta Definição'. A sinopse deste episódio foi criada com o apoio de IA. Saiba mais sobre a aplicação de Inteligência Artificial nas Redações da Impresa.See omnystudio.com/listener for privacy information.

Melanoma hisses "I sue you beeelyun dollursss" at Hunter Biden. Hunter doesn't blink. Secretary HotMama's squeeze, Corey, can't get his dream job as her C.o.S., so he has to stay a man ho'. Russia conveniently hacks Court System. "Are you listening, Russia?" Wanna bet they have the Maxwell GJ testimony now?

Meet Ashley Morgan — a true rarity in the ocular melanoma community. Before her diagnosis, Ashley was already navigating life completely blind. In this powerful and inspiring conversation, Ashley shares her extraordinary journey, resilience, and the realities of facing a cancer diagnosis without sight.   Her story is one of courage, hope, and the unwavering belief that even in darkness, you can still shine.

Dr. Ravi Johar, Chief Medical Officer for United Healthcare of Missouri and Illinois, joins to show to talk about Melanoma, and other types of Skin Cancer.

In this episode, listen to Kelly Romo, PharmD, BCOP; and Shauna Kraft, PharmD, BCOP, share their takeaways from a live webinar on available emerging subcutaneous immunotherapy options for patients with cancer including:Basic mechanism of action and role of hyaluronidase in subcutaneous immunotherapy formulation and available dosing/schedulesAvailable pharmacodynamics/pharmacokinetics, efficacy, and safety data for subcutaneous immunotherapy formulationsCurrent and potential models for administration of subcutaneous immunotherapy in the inpatient setting and day-to-day considerationsPresenters:Kelly Romo, PharmD, BCOPManager, Oncology Medical Drug Management and Customer InitiativesBlue Cross Blue Shield MichiganDetroit, MichiganShawna Kraft, PharmD, BCOPClinical Pharmacist, SpecialistMichigan Medicine, Rogel Cancer CenterClinical Associate ProfessorUniversity of Michigan College of PharmacyAnn Arbor, MichiganResources:Consolidate your learning with a recording from an on-demand webcast, download the slides associated with this discussion, or read an expert text module or commentary on this topic. 

- Treatment Updates from ASCO 2025 on Lung Cancer - Supportive Care Issues - Treatment Updates from ASCO 2025 on Colorectal Cancer - Quality-of-Life Concerns - Update on Pancreas Cancer - Supportive Care Concerns - Update on Lymphoma - Communicating with Your Health Care Team - Updates on Leukemia from ASCO - Managing Treatment Side Effects - Updates on Melanoma from ASCO - Wrap-Up of Part II of Highlights from ASCO

- Treatment Updates from ASCO 2025 on Lung Cancer - Supportive Care Issues - Treatment Updates from ASCO 2025 on Colorectal Cancer - Quality-of-Life Concerns - Update on Pancreas Cancer - Supportive Care Concerns - Update on Lymphoma - Communicating with Your Health Care Team - Updates on Leukemia from ASCO - Managing Treatment Side Effects - Updates on Melanoma from ASCO - Wrap-Up of Part II of Highlights from ASCO

- Treatment Updates from ASCO 2025 on Lung Cancer - Supportive Care Issues - Treatment Updates from ASCO 2025 on Colorectal Cancer - Quality-of-Life Concerns - Update on Pancreas Cancer - Supportive Care Concerns - Update on Lymphoma - Communicating with Your Health Care Team - Updates on Leukemia from ASCO - Managing Treatment Side Effects - Updates on Melanoma from ASCO - Wrap-Up of Part II of Highlights from ASCO

- Treatment Updates from ASCO 2025 on Lung Cancer - Supportive Care Issues - Treatment Updates from ASCO 2025 on Colorectal Cancer - Quality-of-Life Concerns - Update on Pancreas Cancer - Supportive Care Concerns - Update on Lymphoma - Communicating with Your Health Care Team - Updates on Leukemia from ASCO - Managing Treatment Side Effects - Updates on Melanoma from ASCO - Wrap-Up of Part II of Highlights from ASCO

In this episode, listen to Kelly Romo, PharmD, BCOP; and Shauna Kraft, PharmD, BCOP, share their takeaways from a live webinar on available emerging subcutaneous immunotherapy options for patients with cancer including:Basic mechanism of action and role of hyaluronidase in subcutaneous immunotherapy formulation and available dosing/schedulesAvailable pharmacodynamics/pharmacokinetics, efficacy, and safety data for subcutaneous immunotherapy formulationsCurrent and potential models for administration of subcutaneous immunotherapy in the inpatient setting and day-to-day considerationsPresenters:Kelly Romo, PharmD, BCOPManager, Oncology Medical Drug Management and Customer InitiativesBlue Cross Blue Shield MichiganDetroit, MichiganShawna Kraft, PharmD, BCOPClinical Pharmacist, SpecialistMichigan Medicine, Rogel Cancer CenterClinical Associate ProfessorUniversity of Michigan College of PharmacyAnn Arbor, MichiganResources:Consolidate your learning with a recording from an on-demand webcast, download the slides associated with this discussion, or read an expert text module or commentary on this topic. 

This week, Bobbi Conner talks with MUSC Dr. Graciela De Jesus about melanoma skin cancer and prevention strategies.

Bailey O'Brien is an 18-year surthriver of melanoma skin cancer. She was diagnosed three times with melanoma and the third time was considered stage 4 with the cancer in her neck, lung and spine. At that time she pursued alternative treatments and was healed in 10 weeks. She attributes her healing to the Radical Remission healing factors, hard work and the grace of God. www.baileyobrien.com www.instagram.com/baileyobrien330 www.facebook.com/baileyobrien330 Radical Remission Docuseries episode _____________ To learn more about the 10 Radical Remission Healing Factors, connect with a certified RR coach or join a virtual or in-person workshop visit www.radicalremission.com. To watch Episode 1 of the Radical Remission Docuseries for free, visit our YouTube channel here.  To purchase the full 10-episode Radical Remission Docuseries visit Hay House Online Learning. To learn more about Radical Remission health coaching with Liz or Karla, Click Here Follow us on Social Media: Facebook  Instagram YouTube ____________ Join the Radical Remission Thriver Community today! The NEW Radical Remission Thriver Community is an innovative, supportive, and educational platform designed to empower individuals on healing journeys, especially those facing cancer or chronic illness. Drawing inspiration from the Radical Remission movement—which explores the holistic factors contributing to unexpected remissions—this online community will serve as a hub for sharing experiences and knowledge, fostering connection, and providing encouragement.  This unique community is designed to inspire, uplift, and connect individuals who are thriving beyond a diagnosis. Whether you are living with a diagnosis yourself, supporting a loved one, or seeking stories of resilience, you'll find a place of understanding and encouragement here. Join the Community - anyone can join the community and attend the monthly events at our special introductory drop-in price of $10 per event for the month of August. In September the drop-in price will be $20 per event. Click here to join the community monthly events!  

The Australian sun is relentless when it comes to UV rays throughout the year, and it is always wise to check your skin thoroughly for any odd-looking spots or changes. 

Aislinn Walsh, lost her 32-year-old husband, Tom, to melanoma in April last year // Amy Nolan, Director of Clinical Affairs with The Irish Cancer Society.

Missy and Hillary are back! On this episode they talk about the latest with Hillary and melanoma. Upcoming Fundraiser!Hats for Hillary: Sunday, August 10th, 2-5pm, Lake WinnebagoIf you'd like to attend, please reach out to missywilt@gmail.com or call/text Missy.If you can't make the event, but want to donate, you can venmo Hillary at: @hillarycastanedaThanks for listening!

Dr Max Gulhane and Zaid Dahhaj explore the intricate relationship between circadian biology, sun exposure, and skin health. They discuss the contradictions in current sun exposure recommendations, the role of melanin as a protective factor, and the importance of aligning circadian rhythms for optimal skin function.The conversation also delves into the impact of diet on photosensitivity and the potential links between lifestyle choices and skin cancer. Overall, the discussion emphasizes a holistic approach to health that incorporates understanding the body's natural rhythms and the benefits of sunlight.SUPPORT THE REGENERATIVE HEALTH PODCAST 

8 Brain Tumors. Stage 4 Cancer. No Chemo. 13 Years Cancer-Free.What happens when the doctors say, “There's nothing more we can do”?For Georges Cordoba, it was the beginning—not the end.In this astonishing episode, Georges shares his raw, miraculous journey through 10 years of cancer treatment, including 4 brain surgeries, 2 inoperable tumors, and the moment he walked away from conventional medicine—and into divine surrender.He chose holistic healing.He chose emotional release.He chose faith.And now, he coaches others through the very fire he walked through.

Today's guest is Janna "Starshine" Jones, a survivor of Stage IIb Melanoma, leading her to become a volunteer for several organizations and a member of the Board of Directors for Epic Experience. Starshine is Janna's Epic Experience Camp name, and it fits her so perfectly. She shines as bright as the stars and radiates joy and love.We talk about the power of community, rediscovering play in our lives, connecting with others in this "cancer club", journalling, perseverance and finding joy in even the hard times, and so much more! Resources:AIM at Melanoma Foundation: https://www.aimatmelanoma.org/Epic Experience: https://www.epicexperience.org/Be Well Therapy: https://www.bewelltherapy.net/Janna's Facebook: https://www.facebook.com/janna.jones.775Follow:Follow me: https://www.instagram.com/melissagrosboll/My website: https://melissagrosboll.comEmail me: drmelissagrosboll@gmail.com

In this episode, Board Certified Dermatologist, Dr. Jen Haley, discusses: - How does a Basal Cell Cancer present on the skin - Who is predisposed to Basal Cell Cancer & Squamous Cell Cancer? - What are normal changes and abnormal changes with moles? - What are the different things that can grow on your body over time? - Does it reduce your risk of getting melanoma by removing all of your moles? - When to seek expertise from a Board Certified Dermatologist?   Watch this episode on The Radiance Revealed YouTube Channel: https://youtu.be/uJ6L-d-52D0   PRODUCTS / RESOURCES:   Follow Dr. Jen Haley on Instagram @drjenhaley - instagram.com/drjenhaley Connect on LinkedIn:  http://linkedin.com/in/jennifer-haley-md-faad-a4283b46 Book a consultation with Dr. Haley here:  https://app.minnect.com/expert/DrJenHaley Dr. Haley's favorite skincare:  https://www.alumiermd.com?code=5HUKRDKW Dr. Haley's favorite supplements (15% discount): https://us.fullscript.com/welcome/hhaley   #radiancerevealedpodcast

When uveal melanoma spreads to the liver, it's difficult to treat with systemic therapies, but percutaneous hepatic perfusion (PHP) offers an alternative. In this panel discussion, Venkatesh Krishnasamy, M.D., Christy Broman, M.D., and John Dubay, M.D., explain how PHP delivers high-dose chemotherapy directly to the liver while minimizing toxicity. They walk through candidacy, recovery, and how this approach compares to surgery or immunotherapy. Learn how coordination across specialties makes this liver-directed therapy possible.

In this episode I speak with Jenn Frederick who is a cancer survivor who was diagnosed with stage 4 metastatic melanoma and thought that her life was about to come to an end.  You won't believe how she found out she had melanoma, how it didn't look how you might think, and all the incredible challenges she faced during her battle with cancer.Sometimes life throws us huge curveballs and if we are open to it, the silver lining in those dark heavy clouds can lead us to our calling in life like it did for Jenn. She may have began her journey with cancer with a sense of hopelessness and despair, but somehow along the way she was able to transform her fear and doubt into a positive and confident mindset that has led to miraculous results.Take time to listen to this episode and learn just how important mindset is when you are fighting advanced cancer and how Jenn is now inspiring other people to do that too. She knows the power of positivity and believes supporting others on their own journey is her true calling in life.I am sharing her email here because Jenn wants to be there for you too if you are facing any monumental challenges that feel overwhelming and hopeless. jennyk2874@yahoo.comI am also sharing the link to donate to melanoma research. If you are inspired to donate on behalf of Jenn, you can email her to get a direct link for that.https://melanoma.orgClick on the platform of your choice to listen to the latest podcast episode with Jenn, follow the podcast, and write a review so we can spread the news and reach more people! Apple Podcasts https://podcasts.apple.com/us/podcast/the-power-of-community-collaboration-in-sb-podcast/id1548758744Spotify https://open.spotify.com/show/4RWxW7Ni1EHTAywriOwY9z?si=d9c181834529414dGoogle Podcasts https://podcasts.google.com/search/The%20Brain%20BS%20PodcastAmazon Music https://music.amazon.com/podcasts/09208f98-6c21-4fea-abbf-14a495cabd09/the-brain-bs-podcast-learning-to-live-consciouslyI Heart Radiohttps://www.iheart.com/podcast/269-the-brain-bs-podcast-learn-76710324/Pandorahttps://www.pandora.com/podcast/the-brain-bs-podcast-learning-to-live-consciously/PC:60845If you or a loved one are facing a big challenge like advanced cancer, I highly recommend you listen to this episode.Jenn's energy and mindset are contagious and may just change the trajectory of your own battle with cancer.If you want to get in touch with me or connect to get creative about a collaboration, click on the link below.https://www.thebrainbs.com/

To have your question featured in a future video, please email: questions@morses.tv Please include at least: Age, Weight and as much history as possible.